Víctor Díaz

Head of Research OneChain Immunotherapeutics

Seminars

Wednesday 3rd December 2025
Advancing the Development of Autologous & Allogeneic CAR-T Therapies for Haematological & Solid Tumours
12:00 pm
  • Discussing the challenges in evaluating CAR-T cell therapies preclinically and the rationale to select relevant preclinical models
  • Presenting lessons learned to tackle antigen expression and ensure the representation of the patient tumour microenvironment
  • Leveraging model data to predict efficacy and safety of CAR-T therapies to ensure translation to the clinic
Victor Diaz